SCHEMBL6690216

SCHEMBL6690216

NC(=O)c1cccc2c1c1c(O)cc(-c3ccc(Cl)cc3)cc1n2Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 8/20 0.43
ALDH1A1 P00352 2/20 0.41
CCR2 P41597 2/20 0.40
PGR P06401 2/20 0.40
ADRA1D P25100 1/20 0.40
PPARG P37231 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SRC P12931 1/20 0.39
PARP1 P09874 1/20 0.38
SERPINE1 P05121 1/20 0.38
IKBKB O14920 1/20 0.38
CHUK O15111 1/20 0.38
PLA2G1B P04054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6776773 0.96 PLA2G2A (0.42) PLA2G2AALDH1A1CCR2PGRPPARG
SCHEMBL6771677 0.94 PLA2G2A (0.41) PLA2G2AALDH1A1CCR2PGRADRA1D
SCHEMBL6776758 0.94 PLA2G2A (0.50) PLA2G2AALDH1A1CCR2PGRADRA1D
SCHEMBL6694433 0.93 PLA2G2A (0.46) PLA2G2AALDH1A1ADRA1DMEN1POLB
SCHEMBL6773052 0.92 PLA2G2A (0.50) PLA2G2AALDH1A1CCR2PGRADRA1D
SCHEMBL6774857 0.92 FAAH (0.43) PLA2G2ACCR2ADRA1DPPARG
SCHEMBL6770388 0.91 PLA2G2A (0.41) PLA2G2AALDH1A1CCR2PGRADRA1D
SCHEMBL6775434 0.91 ADRA1D (0.46) PLA2G2AALDH1A1ADRA1DMEN1POLB
SCHEMBL6776710 0.91 PLA2G2A (0.41) PLA2G2AADRA1DL3MBTL1PARP1IKBKB
SCHEMBL6772770 0.91 PLA2G2A (0.41) PLA2G2AALDH1A1ADRA1DPOLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP claimed
EP-0952149-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors LILLY CO ELI (US) 2004-06-09 EP disclosed
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed